\-\ Texto\\:\\ \ \(0\)\
\-\ right\\ sided\\ submandibular\\ mass\\ which\\ was\\ nontender\\,\\ freely\\ mobile\\ and\\ compressable\\.\ \(0\)\
\-\ patient\\ was\\ scheduled\\ for\\ a\\ right\\ sialodenectomy\\.\ \(0\)\
\-\ well\\ defined\\ 2\\.3\\ x\\ 2\\.3\\ x\\ 4\\.5\\ cm\\ cystic\\ mass\\ arising\\ from\\ the\\ region\\ of\\ the\\ right\\ sublingual\\ gland\\.\\ \\ the\\ mass\\ is\\ t2\\ bright\\ with\\ t1\\ dark\\ with\\ peripheral\\ enhancement\\ after\\ contrast\\.\ \(0\)\
\-\ ranula\ \(62\)\
\-\ ranula\ \(62\)\
\-\ abscess\ \(594\)\
\-\ salivary\\ tumor\ \(0\)\
\-\ branchial\\ cleft\\ cyst\ \(12\)\
\-\ 18\\ yo\\ female\\ with\\ enlarging\\ right\\ sided\\ submandibular\\ mass\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ranula\\:\\ 0\\.43256646918208724\ \(0\)\
\-\ submandibular\\:\\ 0\\.33852467702448774\ \(0\)\
\-\ compressable\\:\\ 0\\.23406820196584105\ \(0\)\
\-\ sialodenectomy\\:\\ 0\\.23406820196584105\ \(0\)\
\-\ mass\\:\\ 0\\.22362885206088143\ \(0\)\
\-\ sublingual\\:\\ 0\\.20587969560023794\ \(0\)\
\-\ right\\:\\ 0\\.19410313852491443\ \(0\)\
\-\ sided\\:\\ 0\\.18829781250333444\ \(0\)\
\-\ freely\\:\\ 0\\.18413948626756957\ \(0\)\
\-\ salivary\\:\\ 0\\.17254232349303403\ \(0\)\
\-\ branchial\\:\\ 0\\.16926233851224387\ \(0\)\
\-\ mobile\\:\\ 0\\.1443538171274309\ \(0\)\
\-\ dark\\:\\ 0\\.1435878413137095\ \(0\)\
\-\ nontender\\:\\ 0\\.13786236064910706\ \(0\)\
\-\ enlarging\\:\\ 0\\.13668246154301603\ \(0\)\
\-\ scheduled\\:\\ 0\\.13583183278469477\ \(0\)\
\-\ bright\\:\\ 0\\.13343709534539616\ \(0\)\
\-\ cleft\\:\\ 0\\.13219732355599964\ \(0\)\
\-\ gland\\:\\ 0\\.11889749416821858\ \(0\)\
\-\ arising\\:\\ 0\\.1162952264025914\ \(0\)\
\-\ 18\\:\\ 0\\.1109106375126229\ \(0\)\
\-\ peripheral\\:\\ 0\\.10466256680307133\ \(0\)\
\-\ defined\\:\\ 0\\.10441545461148599\ \(0\)\
\-\ was\\:\\ 0\\.10201873795746101\ \(0\)\
\-\ abscess\\:\\ 0\\.09398460504414341\ \(0\)\
\-\ yo\\:\\ 0\\.09144004250276812\ \(0\)\
\-\ t1\\:\\ 0\\.09119403597555019\ \(0\)\
\-\ cystic\\:\\ 0\\.08815017184116448\ \(0\)\
\-\ the\\:\\ 0\\.08761487755712835\ \(0\)\
\-\ region\\:\\ 0\\.08754844245656794\ \(0\)\
\-\ with\\:\\ 0\\.08597981415258327\ \(0\)\
\-\ cyst\\:\\ 0\\.08443210374446161\ \(0\)\
\-\ enhancement\\:\\ 0\\.08424467935934274\ \(0\)\
\-\ t2\\:\\ 0\\.0842073582120587\ \(0\)\
\-\ cm\\:\\ 0\\.08405861411877637\ \(0\)\
\-\ tumor\\:\\ 0\\.07655696288191284\ \(0\)\
\-\ contrast\\:\\ 0\\.07111537110877254\ \(0\)\
\-\ after\\:\\ 0\\.07100366747464441\ \(0\)\
\-\ well\\:\\ 0\\.07087026188347208\ \(0\)\
\-\ female\\:\\ 0\\.07062747200604769\ \(0\)\
\-\ which\\:\\ 0\\.06655325304415932\ \(0\)\
\-\ from\\:\\ 0\\.058129650717959794\ \(0\)\
\-\ patient\\:\\ 0\\.047604923069372675\ \(0\)\
\-\ for\\:\\ 0\\.04436186242136204\ \(0\)\
\-\ is\\:\\ 0\\.04008282758748681\ \(0\)\
\-\ and\\:\\ 0\\.030244367749669227\ \(0\)\
\-\ of\\:\\ 0\\.02864282397036401\ \(0\)\
